为研究流式细胞计测定DNA指数和／或倍体状况来否司以作为诱导化疗疗效和生成的预测指标，＿该作者把未曾治疗、经活检证实力头颈部群状细胞癌51例患者作为研究对象。临床分期为I一v期，年龄为38ng0岁，平均年龄59岁。肿瘤原发部位：下咽癌18例、口咽癌15例、很咽癌10例、喉癌8 To determine whether the flow cytometry was used to determine the index of DNA and/or the status of ploidy as a predictor of efficacy and production of induction chemotherapy, the authors treated 51 patients with untreated and biopsy-proven head and neck group cell carcinoma. As research target. Clinical stage I-v period, age 38ng 0 years old, average age 59 years. Primary tumor sites: Hypopharyngeal cancer in 18 cases, oropharyngeal cancer in 15 cases, very pharyngeal cancer in 10 cases, laryngeal cancer 8